12 days left, over 2000% of our goal raised!
With $70,000 left in the round and time running out, we urge any interested parties to invest soon.
We are closing in on a $1m+ fund raise. This brings our total capital raised to date over $2m.
- In this round we have received contributions from investors with diverse backgrounds including retired angels, military veterans, founders of healthcare companies, leading physicians, nurses and other healthcare professionals, directors from Google, Abbott and Boehringer Ingelheim among other companies and supporters with a commitment to social impact.
We have filed two additional patents for newly developed reagents and tests measuring therapeutic levels of a blockbuster drug and an innovative heart failure and sepsis biomarker
- One patent application covers the reagents and test for a >$5B revenue drug as part of our development partnership with a top 5 global pharmaceutical company. and the other patent covers the reagents and test for an innovative heart failure and sepsis biomarker as part of our contract with DARPA/BARDA.
We have completed the second milestone of our DARPA/BARDA contract and are starting the final milestone with strong potential for further development contracts from the government
- We have completed initial validation of a new heart failure and sepsis related test, triggering a $50,000 payment and moving us into the final phase of our contract. In the past, completion of these initial contracts has led to significant follow on contracts to expand and bring products to market. We are excited about pursuing this opportunity over the coming months!
As this raise comes to an end, we will be looking to hire full time engineers and scientists to grow our team in Philadelphia and accelerate the company's growth. Thank you for being part of our mission.